SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " Data " 7,281 found 🔀 AI-powered Shuffle
Apple's revamped Health app will calculate your 'health age' and readiness score
The update uses Apple Intelligence to make better sense of your health data.
The Apple Watch Series 12 Will Track More Than Just Health Data
Even with a return of ceramic frames, the most important new features for Series 12 are all built around health and conversation tracking.
FSU computer scientist earns NSF CAREER Award for data compression research
A Florida State University computer scientist has earned one of the most prestigious awards available to early career faculty for developing
Google DeepMind’s AlphaGenome Takes Aim at One of Genetics’ Biggest Problems
Google DeepMind has released a huge new dataset that could make it easier for scientists to study how changes in our DNA affect the way the body works. Called AlphaGenome Atlas, it contains predictions for more than 9 billion possible single-letter changes in the human genome. The dataset is about one petabyte in size and […]
Stores collecting biometric data in Monroe County must tell customers
Monroe County mandates businesses to post notices when using biometric identification technology, enhancing transparency and protecting consumers.
An onslaught of midterm polling is coming. Here’s how to sort through it
If read carefully, high-quality polls can still tell you a lot about how this year’s midterms are shaping up – and keeping a few simple questions in mind can help you sort through the overwhelming and sometimes overblown deluge of data.
Tarrant passes 1-year moratorium on data center business licenses
At Tuesday’s city council meeting, Tarrant city leaders passed a temporary moratorium against approving business licenses for data centers.
Florida Poly partners with Detroit Tigers to enhance student access to sport science and data analytics
'This partnership strengthens our ability to translate research into real decisions for our players.'
Health Plans Have the SDoH Data. New Research Shows only 7% are Highly Effective at Using It.
Health plans are collecting significant amounts of social drivers of health (SDoH) data, but only few believe they are highly effective at turning that information into action, according to new research from national health care consultancy Sage Growth Partners. Sage's survey of 50 health plan leaders found that 60% collect SDoH screening data, yet just 7% describe their organizations as "very effective" at acting on that information.
ASL Environmental Sciences Brings ADCP Training To PRODIGY Field School
ASL Environmental Sciences equipped graduate students with hands-on ADCP mooring experience at the 2026 PRODIGY field school in Bamfield, British Columbia, covering the full cycle from mooring design and deployment to data analysis. The company plans continued involvement through 2028.
VA Health Records Overhaul Stalls Despite Restart Push
VA's electronic health records modernization hits another roadblock. Learn why the fourth attempt faces delays and what it means for veterans' care.
Hoping customers would return after Operation Metro Surge, immigrant businesses are still waiting
These anecdotal reports match preliminary data from government and other researchers.
The Cost of Cutting American Science: How Federal Cuts Diminish Public Health Capacity
Among the federal government’s many responsibilities is the work it does to protect public health. Federal agencies monitor our food supply to ensure safety, conduct research to better understand emerging health threats, provide funding for public health programs in communities and work to detect and respond to disease outbreaks. Americans rely on these efforts every day—in a 2024 online survey, 74% of respondents said that “if the federal government issued safety guidance about food you eat regularly,” they would follow it. Changes to Federal Public Health Capacity The Trump administration’s efforts to reshape the federal government have resulted in significant impacts on our nation’s public health capacity over the past 20 months, affecting the response to health concerns such as measles, Ebola and cyclosporiasis. Agencies with core public health, food safety and disease prevention responsibilities experienced large workforce decreases during the first year of the administration. At the Centers for Disease Control and Prevention, for instance, the workforce in February 2026 was 26.7% smaller than in September 2024 before the start of the Trump administration. The Food and Drug Administration saw a similarly steep decline of 21.6%. Agencies such as the National Institutes of Health, Substance Abuse and Mental Health Services Administration and Food Safety and Inspection Service also experienced large workforce decreases. (function(){function e(){window.addEventListener(`message`,function(e){if(e.data[`datawrapper-height`]!==void 0){var t=document.querySelectorAll(`iframe`);for(var n in e.data[`datawrapper-height`])for(var r=0,i;i=t[r];r++)if(i.contentWindow===e.source){var a=e.data[`datawrapper-height`][n]+`px`;i.style.height=a}}})}e()})(); Changes can also be seen in crucial public health occupations. The number of federal food inspectors, for example, decreased by more than half between September 2024 and February 2026, going from 1,035 to 473. This is the lowest number of food inspectors employed by the federal government since at least 2005. By February 2026, there were also 33.3% fewer federal public health program specialists, whose work includes advising federal funding recipients on public health activities and analyzing the effectiveness of public health programs. Government’s capacity is diminished as employees with specialized knowledge and experience in protecting the public and responding to health risks depart, leaving agencies less prepared to carry out their public health missions. There also have been vacancies in critical high-level leadership positions at public health agencies, most notably at the CDC, which had a permanent Senate-confirmed director for less than a month between January 2025 and early August 2026. Although the CDC has previously been led by acting directors at the start of an administration, the nearly yearlong gap since the departure of the administration’s first permanent director in August 2025 is without precedent. As of August 2026, the FDA is also currently without a Senate-confirmed commissioner following the previous commissioner’s resignation in May 2026. Additionally, public health agencies are experiencing increased politicization of their leadership ranks. In agencies such as the CDC and Food Safety and Inspection Service, the number of individuals in the Senior Executive Service—the most senior career leaders in government—has declined significantly, while at the same time the number of political appointees has reached record levels. (function(){function e(){window.addEventListener(`message`,function(e){if(e.data[`datawrapper-height`]!==void 0){var t=document.querySelectorAll(`iframe`);for(var n in e.data[`datawrapper-height`])for(var r=0,i;i=t[r];r++)if(i.contentWindow===e.source){var a=e.data[`datawrapper-height`][n]+`px`;i.style.height=a}}})}e()})(); (function(){function e(){window.addEventListener(`message`,function(e){if(e.data[`datawrapper-height`]!==void 0){var t=document.querySelectorAll(`iframe`);for(var n in e.data[`datawrapper-height`])for(var r=0,i;i=t[r];r++)if(i.contentWindow===e.source){var a=e.data[`datawrapper-height`][n]+`px`;i.style.height=a}}})}e()})(); At the CDC, for example, the number of career SES decreased 42.9% between December 2024 and February 2026, while the number of non-Senate confirmed political appointees at the agency was six times larger than the agency’s historical average from 2009 and 2024. Knowledgeable career leaders are integral to the ability of public health agencies to carry out their work with scientific integrity and professional judgment, and rapid leadership turnover and increased politicization threaten agencies’ ability to make evidence-based decisions to protect our health. The upheaval and politicization in public health agencies have also negatively affected employee engagement. Strong employee engagement is crucial to the ability of agencies to carry out their mission and successfully provide essential services to the public. In the 2025 Public Service Viewpoint Survey conducted by the Partnership for Public Service, the Department of Health and Human Services—which encompasses major public health agencies such as the CDC and FDA—had an employee engagement and satisfaction score of 20.4 out of 100, one of the lowest among large agencies. Only 2.8% of HHS employees indicated trust in their political leaders and only 8.7% reported confidence that they could report a suspected violation of law or regulation without retaliation. Employees at HHS also reported that the agency’s ability to provide services to the public had suffered. Nearly half of employees at HHS, 47.5%, said their work unit was worse at delivering quality services compared to its performance in 2024. In addition, 57.8% said their work unit was performing worse at fulfilling stakeholder needs. In addition to the work done within federal agencies, the federal government also distributes significant funding for public health and disease prevention work to state and local governments, nonprofits and small businesses—funding which has been significantly disrupted. At the CDC, for example, there was a 71.9% decrease in the amount of project grant funding issued in fiscal year 2025 compared to fiscal year 2024. The FDA also issued far less funding in fiscal year 2025—a 21.3% decrease from its fiscal year 2024 funding. Changes in federal funding include the ending of grants to community organizations that worked on HIV prevention and the cancellation of funding for research into improvements to patient safety and healthcare quality. These changes go beyond federal agencies to impact the broader public health ecosystem, including the state and local health departments responsible for much of the on-the-ground public health work in their communities. About 80% of the CDC’s domestic funding is directed towards state and local partners—meaning that cuts to CDC funding can ultimately result in cuts to state and local public health capacity. Federal agencies also provide expertise and assistance to state and local health agencies as they deal with particular health challenges, but workforce cuts have resulted in fewer federal employees available to help. The Impact of Changes to Public Health Capacity These changes to federal public health capacity are not abstract concerns. Disrupted programs, reduced funding and lost expertise at public health agencies across all levels of government threaten the public’s physical well-being and safety. In some cases, this has already led to harm. The most immediate impacts of federal cuts were seen in interruptions to ongoing public health programs and crisis responses. In one instance, when CDC grants were canceled during the 2025 Texas measles outbreak—the most severe measles outbreak in 25 years—public health officials in Lubbock, Texas were forced to pause parts of their measles response work supported by the frozen funding. Lubbock’s director of public health further said that a lack of available CDC experts to reach out to for advice “definitely” impacted the department’s response to the measles crisis. Cuts to federal funding also forced Dallas County Health and Human Services to cut staff and cancel 50 community vaccination clinics during the outbreak. Public health work outside of major outbreak responses was also disrupted. For example, in April 2025, the Milwaukee Public Health Department was unexpectedly unable to reach experts on lead poisoning due to firings at the CDC when responding to concerns about lead contamination in Milwaukee public schools. Due to federal workforce cuts, several programs at the CDC, including Alzheimer’s and epilepsy programs, have also become trapped in limbo—existing on paper, but without the staff necessary to operate. More recent crises reveal how federal cuts have weakened the public health infrastructure needed to prevent and respond to dangerous new outbreaks. Internationally, cuts at the U.S. Agency for International Development eliminated funding for disease testing and contact tracing abroad, which delayed detection of and responses to the 2026 Ebola outbreak in the Democratic Republic of Congo. While international outbreaks may seem far removed, the unchecked spread of disease in any country can quickly pose a danger to economic well-being, security and health around the world. Within the United States, public health cuts inhibited responses to the summer 2026 outbreak of the food-borne parasite cyclospora. At the federal level, cuts to funding for lab equipment and for CDC staff with expertise in parasitic infections—including 9 out of 11 staff members at the lab responsible for identifying parasitic outbreaks in 2025— contributed to the largest reporting delay in outbreak cases at the CDC in 15 years. Conflicting communications from the FDA about the source of the outbreak, which followed cuts to the agency’s communications department, additionally led to confusion among the public about how to best avoid infection. At the same time, cuts to HHS funding and support for local and state public health slowed some health departments’ responses to the crisis. The exact costs of these delays, constraints and confusion in public health responses are difficult to estimate. However, their message is clear: federal cuts have already made containing threats to public health even more of a challenge. Conclusion Protecting public health—from food safety to disease prevention—is one of the federal government’s most important missions. Dramatic and haphazard cuts to federal agencies and funding have already disrupted the public health system, impacting the response to challenges such as measles, lead poisoning and cyclosporiasis. The U.S. public health system needed improvement before these disruptions. Since 2022, federal leadership and coordination in response to public health outbreaks has been on the Government Accountability Office’s High-Risk List of areas in need of attention to improve government effectiveness and efficiency. Recent cuts only compound these concerns. The chaotic dismantling of government and resulting disruptions to crucial functions like public health and disease prevention highlight the need for meaningful reform and concrete policy proposals to reimagine how government can better serve the public and be more effective, responsive and accountable. To learn more about the impact of federal cuts to public health and science more broadly, visit The Cost of Cutting American Science. Learn more For more information on the Partnership for Public Service’s government reform initiative, visit Government for a New Era. View here In line with The Cost of Cutting American Science, federal workforce data in this brief is as of February 2026
The Cost of Cutting American Science: How Federal Cuts Diminish Public Health Capacity
Among the federal government’s many responsibilities is the work it does to protect public health. Federal agencies monitor our food supply to ensure safety, conduct research to better understand emerging health threats, provide funding for public health programs in communities and work to detect and respond to disease outbreaks. Americans rely on these efforts every day—in a 2024 online survey, 74% of respondents said that “if the federal government issued safety guidance about food you eat regularly,” they would follow it. Changes to Federal Public Health Capacity The Trump administration’s efforts to reshape the federal government have resulted in significant impacts on our nation’s public health capacity over the past 20 months, affecting the response to health concerns such as measles, Ebola and cyclosporiasis. Agencies with core public health, food safety and disease prevention responsibilities experienced large workforce decreases during the first year of the administration. At the Centers for Disease Control and Prevention, for instance, the workforce in February 2026 was 26.7% smaller than in September 2024 before the start of the Trump administration. The Food and Drug Administration saw a similarly steep decline of 21.6%. Agencies such as the National Institutes of Health, Substance Abuse and Mental Health Services Administration and Food Safety and Inspection Service also experienced large workforce decreases. (function(){function e(){window.addEventListener(`message`,function(e){if(e.data[`datawrapper-height`]!==void 0){var t=document.querySelectorAll(`iframe`);for(var n in e.data[`datawrapper-height`])for(var r=0,i;i=t[r];r++)if(i.contentWindow===e.source){var a=e.data[`datawrapper-height`][n]+`px`;i.style.height=a}}})}e()})(); Changes can also be seen in crucial public health occupations. The number of federal food inspectors, for example, decreased by more than half between September 2024 and February 2026, going from 1,035 to 473. This is the lowest number of food inspectors employed by the federal government since at least 2005. By February 2026, there were also 33.3% fewer federal public health program specialists, whose work includes advising federal funding recipients on public health activities and analyzing the effectiveness of public health programs. Government’s capacity is diminished as employees with specialized knowledge and experience in protecting the public and responding to health risks depart, leaving agencies less prepared to carry out their public health missions. There also have been vacancies in critical high-level leadership positions at public health agencies, most notably at the CDC, which had a permanent Senate-confirmed director for less than a month between January 2025 and early August 2026. Although the CDC has previously been led by acting directors at the start of an administration, the nearly yearlong gap since the departure of the administration’s first permanent director in August 2025 is without precedent. As of August 2026, the FDA is also currently without a Senate-confirmed commissioner following the previous commissioner’s resignation in May 2026. Additionally, public health agencies are experiencing increased politicization of their leadership ranks. In agencies such as the CDC and Food Safety and Inspection Service, the number of individuals in the Senior Executive Service—the most senior career leaders in government—has declined significantly, while at the same time the number of political appointees has reached record levels. (function(){function e(){window.addEventListener(`message`,function(e){if(e.data[`datawrapper-height`]!==void 0){var t=document.querySelectorAll(`iframe`);for(var n in e.data[`datawrapper-height`])for(var r=0,i;i=t[r];r++)if(i.contentWindow===e.source){var a=e.data[`datawrapper-height`][n]+`px`;i.style.height=a}}})}e()})(); (function(){function e(){window.addEventListener(`message`,function(e){if(e.data[`datawrapper-height`]!==void 0){var t=document.querySelectorAll(`iframe`);for(var n in e.data[`datawrapper-height`])for(var r=0,i;i=t[r];r++)if(i.contentWindow===e.source){var a=e.data[`datawrapper-height`][n]+`px`;i.style.height=a}}})}e()})(); At the CDC, for example, the number of career SES decreased 42.9% between December 2024 and February 2026, while the number of non-Senate confirmed political appointees at the agency was six times larger than the agency’s historical average from 2009 and 2024. Knowledgeable career leaders are integral to the ability of public health agencies to carry out their work with scientific integrity and professional judgment, and rapid leadership turnover and increased politicization threaten agencies’ ability to make evidence-based decisions to protect our health. The upheaval and politicization in public health agencies have also negatively affected employee engagement. Strong employee engagement is crucial to the ability of agencies to carry out their mission and successfully provide essential services to the public. In the 2025 Public Service Viewpoint Survey conducted by the Partnership for Public Service, the Department of Health and Human Services—which encompasses major public health agencies such as the CDC and FDA—had an employee engagement and satisfaction score of 20.4 out of 100, one of the lowest among large agencies. Only 2.8% of HHS employees indicated trust in their political leaders and only 8.7% reported confidence that they could report a suspected violation of law or regulation without retaliation. Employees at HHS also reported that the agency’s ability to provide services to the public had suffered. Nearly half of employees at HHS, 47.5%, said their work unit was worse at delivering quality services compared to its performance in 2024. In addition, 57.8% said their work unit was performing worse at fulfilling stakeholder needs. In addition to the work done within federal agencies, the federal government also distributes significant funding for public health and disease prevention work to state and local governments, nonprofits and small businesses—funding which has been significantly disrupted. At the CDC, for example, there was a 71.9% decrease in the amount of project grant funding issued in fiscal year 2025 compared to fiscal year 2024. The FDA also issued far less funding in fiscal year 2025—a 21.3% decrease from its fiscal year 2024 funding. Changes in federal funding include the ending of grants to community organizations that worked on HIV prevention and the cancellation of funding for research into improvements to patient safety and healthcare quality. These changes go beyond federal agencies to impact the broader public health ecosystem, including the state and local health departments responsible for much of the on-the-ground public health work in their communities. About 80% of the CDC’s domestic funding is directed towards state and local partners—meaning that cuts to CDC funding can ultimately result in cuts to state and local public health capacity. Federal agencies also provide expertise and assistance to state and local health agencies as they deal with particular health challenges, but workforce cuts have resulted in fewer federal employees available to help. The Impact of Changes to Public Health Capacity These changes to federal public health capacity are not abstract concerns. Disrupted programs, reduced funding and lost expertise at public health agencies across all levels of government threaten the public’s physical well-being and safety. In some cases, this has already led to harm. The most immediate impacts of federal cuts were seen in interruptions to ongoing public health programs and crisis responses. In one instance, when CDC grants were canceled during the 2025 Texas measles outbreak—the most severe measles outbreak in 25 years—public health officials in Lubbock, Texas were forced to pause parts of their measles response work supported by the frozen funding. Lubbock’s director of public health further said that a lack of available CDC experts to reach out to for advice “definitely” impacted the department’s response to the measles crisis. Cuts to federal funding also forced Dallas County Health and Human Services to cut staff and cancel 50 community vaccination clinics during the outbreak. Public health work outside of major outbreak responses was also disrupted. For example, in April 2025, the Milwaukee Public Health Department was unexpectedly unable to reach experts on lead poisoning due to firings at the CDC when responding to concerns about lead contamination in Milwaukee public schools. Due to federal workforce cuts, several programs at the CDC, including Alzheimer’s and epilepsy programs, have also become trapped in limbo—existing on paper, but without the staff necessary to operate. More recent crises reveal how federal cuts have weakened the public health infrastructure needed to prevent and respond to dangerous new outbreaks. Internationally, cuts at the U.S. Agency for International Development eliminated funding for disease testing and contact tracing abroad, which delayed detection of and responses to the 2026 Ebola outbreak in the Democratic Republic of Congo. While international outbreaks may seem far removed, the unchecked spread of disease in any country can quickly pose a danger to economic well-being, security and health around the world. Within the United States, public health cuts inhibited responses to the summer 2026 outbreak of the food-borne parasite cyclospora. At the federal level, cuts to funding for lab equipment and for CDC staff with expertise in parasitic infections—including 9 out of 11 staff members at the lab responsible for identifying parasitic outbreaks in 2025— contributed to the largest reporting delay in outbreak cases at the CDC in 15 years. Conflicting communications from the FDA about the source of the outbreak, which followed cuts to the agency’s communications department, additionally led to confusion among the public about how to best avoid infection. At the same time, cuts to HHS funding and support for local and state public health slowed some health departments’ responses to the crisis. The exact costs of these delays, constraints and confusion in public health responses are difficult to estimate. However, their message is clear: federal cuts have already made containing threats to public health even more of a challenge. Conclusion Protecting public health—from food safety to disease prevention—is one of the federal government’s most important missions. Dramatic and haphazard cuts to federal agencies and funding have already disrupted the public health system, impacting the response to challenges such as measles, lead poisoning and cyclosporiasis. The U.S. public health system needed improvement before these disruptions. Since 2022, federal leadership and coordination in response to public health outbreaks has been on the Government Accountability Office’s High-Risk List of areas in need of attention to improve government effectiveness and efficiency. Recent cuts only compound these concerns. The chaotic dismantling of government and resulting disruptions to crucial functions like public health and disease prevention highlight the need for meaningful reform and concrete policy proposals to reimagine how government can better serve the public and be more effective, responsive and accountable. To learn more about the impact of federal cuts to public health and science more broadly, visit The Cost of Cutting American Science. Learn more For more information on the Partnership for Public Service’s government reform initiative, visit Government for a New Era. View here In line with The Cost of Cutting American Science, federal workforce data in this brief is as of February 2026
EverTrue Acquires Aidentified's Philanthropy Business, Securing Exclusive Data Rights to Advance AI-Powered Fundraising
/PRNewswire/ -- EverTrue, the philanthropy-first intelligence platform for fundraising teams, today announced an exclusive partnership with Aidentified, a data...
H1 acquires Defacto Health to expand provider network intelligence
H1 has acquired Defacto Health, a healthcare data company focused on provider network intelligence, in a move to expand its offerings for health plans and strengthen its healthcare data assets. | H1 has acquired Defacto Health, a healthcare data company focused on provider network intelligence, in a move to expand its offerings for health plans and strengthen its healthcare data assets.
BBH Launches a New Technology Business, Braid, Solving for Intelligent Data Transformation
BOSTON, September 09, 2026--Brown Brothers Harriman (BBH) today announced the launch of a new technology affiliate, Braid LLC, focused on solving enterprise data transformation for financial services. Braid offers an AI-native data transformation platform that gives firms a scale solution to transform, connect, and manage their data with confidence.
HOMETOWN HEALTH: The warning signs of suicide risk in men that often go unnoticed
CDC data shows the suicide rate among men is significantly higher than it is for women.
Indigenous Arts Initiative will offer workshops on arts, entertainment industry
The Indigenous Arts Initiative, which includes partners from the University of Kansas, will bring two distinguished Indigenous artists and educators to Lawrence this September for a series of free public workshops exploring art, culture, storytelling and filmmaking.
Indiana counties' response to data centers reflects broader political risk
Indiana illustrates both the shifting political risk for data centers and the direction of the infrastructure finance discussion on this issue.
Curbing pay-to-play in Chicago politics
Close a loophole to limit political donations from city contractors. Also, data centers, ICE, right-to-die law and the Bears.
Democrats demand Trump administration halt collection of patients’ ER records
A group of Democratic lawmakers is calling for the Trump administration to suspend a new surveillance program it quietly launched to collect the personal and identifiable health data of Americans who visit emergency rooms.
Can Ohio business leaders shift data center opinions? Business leaders hope so
Ohio business leaders are launching a campaign to counter what they see as data center misinformation and convince skeptical communities that the facilities can be good neighbors.
Gilead opens new research centre bringing together oncology, inflammation and research data science teams
The centre in California supports the company’s $32bn US investment
Epic v. Health Gorilla: “Working as Designed”
We’ve been on a bit of a legal bender since just before Labor Day, so let’s keep a good thing going! As predicted, Epic does not want its case against Health Gorilla consolidated with the data breach cases, so it filed a motion to vacate the conditional transfer. And because they had to explain to the Panel why this case is different, they put a good chunk of previously unseen Epic v. Health Gorilla discovery record on the public docket! Roll the tape! The Case Against Consolidation Before we get to the fun stuff, let’s do the housekeeping. Epic's motion boils down to three arguments (sorted in ascending order of how well they land): A judge has already decided this. Judge Olguin declined to relate the fraud action to another ELU case (Patterson v. UVA Health), holding that the two do not call for determination of substantially similar questions of law or fact. Epic asks the Panel to treat that (a Rule 42 ruling) as law of the case. The overlap is thin. The three common questions Health Gorilla and the Panel identified are neither numerous nor complex (the qualities the Panel looks for before centralizing). Moreover, they are outnumbered by the questions unique to each side: The breach cases turn on security architecture, notification timing, and patient-level access. The fraud action turns on false treatment attestations and breaches of the framework agreements. Consolidation costs more than it saves. 17 of 21 parties in the fraud action do not appear in a breach case. The cases are also at very different stages: Olguin has a scheduling order running through a January 2028 trial while the breach actions are much more nascent. I like the last two more than the first because they attack the basic economics of an MDL: there just may not be enough shared discovery here to justify dragging all the defendants and a relatively mature fraud case all the way to Florida. On the other hand (while I know exceedingly little about MDL and Rule 42), I have a hard time seeing why a district judge's decision about his own docket would control what the Panel does with the separate § 1407 question. I might be reading between the lines too much, but I sorta think Epic's own brief half-concedes this, framing the two provisions as "two sides of the same coin" but then adding "respectfully submit" (which is often lawyer speak for “we know this is a reach”). The Ladder Gets More Rungs Anyway, the arguments are not why you're here (aside from the lawyers, maybe). Back in June, we discussed how Epic was using the smaller defendants to build an evidentiary ladder toward Health Gorilla and Unit 387. Turns out discovery has been adding a few rungs of its own.
The five deep-sea arrays of the Ocean Observatories Initiative had been streaming continuous readings from the Atlantic and Pacific since 2016, and in May 2026 the National Science Foundation said four would be pulled out of the water before reversing course on June 18
The five deep-sea arrays of the Ocean Observatories Initiative streamed continuous readings from the Atlantic and Pacific for a decade. In May 2026 the National Science Foundation moved to pull four of them out. A bipartisan Senate revolt reversed the plan — but the data gap and the deeper funding cliff remain.
Kingdom Hearts 4's Disney Worlds May Have Been Revealed By Massive Steam Leak
The achievement database Exophase has listed achievements for several games, including some that haven't been announced
Aroostook County couple launches ‘walking taco’ business after eclipse success
A soft opening for Jack’s Walkin’ Tacos is planned for Oct. 1.
Multiple amiibo Listings Have Apparently Been Spotted On GameStop's Internal Database
New Zelda amiibo were announced yesterday
Gov. Tina Kotek says she now supports a data center moratorium
The Oregon governor is escalating her stance on the facilities as they emerge as a political hot potato.
The 98 Biggest TV Show Flops, Bombs and Misses in the First Half of 2026
(Welcome to the Entertainment Strategy Guy, a newsletter on the entertainment industry and business strategy. I write a weekly Streaming Ratings Report and a bi-weekly strategy column, along with occasional deep dives into other topics, like today’s article. Please subscribe.) In July, I updated my look at how the “streaming bubble” popped since 2023, showing the decline in streaming TV shows over time. But after compiling and analyzing and writing about over one hundred TV show flops in the first half of 2026—I counted 99 “nominees” and there are even more honorable mentions—I couldn’t have told you that the number of shows is going down. When it comes to scripted, English-language TV shows, it feels like we have as many bombs as ever. I don’t keep a specific count, but some streamers probably had as many flops as they’ve ever had.1 That’s right, it’s time for part two of my analysis of the biggest flops, bombs and misses on streaming in the first half of 2026. Two weeks ago, I took a look at films. Today, TV shows. If you want to read the full methodology for how I assemble this list, you can find it at the bottom of this article. In short, this list is… ...scripted and unscripted TV shows,...from the nine major streamers,...in the US (using US-only ratings),...excluding true crime, kids and foreign-language shows,...that got no/poor ratings,...from Jan-2026 to the end of June-2026. Reminder: this article does not represent my personal opinion—many of these shows are great!—but I follow the data, and a miss is a miss and a bomb is a bomb. Also, price matters. If a TV show costs north of $100 million, it needs to get lots and lots of streaming viewership to justify that budget. As with past editions, I ordered this list by streamer, going from best (fewest flops) to worst (the most misses)—taking the size of the flops into consideration—and like the last edition, three or four streamers vied to take the win/loss of having the most flops. (But the actual winner is no surprise.) I try to avoid tooting my own horn too much, but seriously, in just under 5,000 words (including the methodology section) I provide a mostly comprehensive overview of the eight major streamers (Netflix, Disney+, Prime Video, Hulu, HBO Max, Peacock, Paramount+, and Apple TV) for the first half of the year, mentioning most of their hits and all their misses. It summarizes the entire first half of 2026! If you want to support this work, please subscribe. Subscribe Tubi Big Mood Boarders The Freak Brothers Twenty Twenty Six Honorable Mentions: Busted on Bodycam, Deestroying the Pitch, Destination World Cup 2026 I don’t think that Tubi spends all that much making or (mostly) licensing these original TV shows—Big Mood, Boarders and Twenty Twenty Six all come from the UK—but they’re not free and they didn’t chart anywhere. Winner: The Freak Brothers Have you even heard of this show? It’s an animated comedy...that’s on its third season! And Pete Davidson, Woody Harrelson, John Goodman and Tiffany Haddish all provide voice talent for it. Yes, animated shows don’t cost as much as live action shows, but cheap isn’t free! So a show with this level of talent needs to perform better. Disney+ Daredevil: Born Again Star Wars: Maul – Shadow Lord Honorable Mentions: Behind the Attraction, Donna Hay Coastal Celebrations, We Call It Imagineering Disney+ doesn’t make all that many original shows anymore. They had two flops, and one was animated. Their one not-a-miss show, Wonder Man, got just good enough viewership to not be considered a “miss”...but it’s since been cancelled. At this point, Disney has pivoted entirely away from making big budget TV shows for Disney+ to making...almost nothing for Disney+? Sure, Disney’s spending circa 2019-2022 was unsustainable, but now they’re pivoting too far in the other direction. At some point, Disney needs to stop shifting strategies so wildly. Really, Disney should have made fewer shows for Disney+ at launch and the shows they did make at that time needed to be made at more reasonable budgets. And they should adopt that strategy now. Winner: Daredevil: Born Again Daredevil, the Marvel Comics character, is on my personal Mount Rushmore of favorite superheroes, so it pains me to give him the win/loss today, but this show deserves it. I’ll repeat my hot take from last spring: “Based on his popularity, Daredevil should be in movies, and probably ones that cost a lot less than the MCU’s usual price tag. Disney/Bob Iger/Ike Perlmutter (who, based on reporting, made the decision) made a huge mistake selling TV shows to Netflix in the 2010s, thus limiting this character to the small screen. Daredevil could have anchored Marvel’s post-Infinity War plans, and if he did, the MCU would probably be in a better place than it is now.” HBO Max We’re just getting started with this issue, but the rest is for paid subscribers of the Entertainment Strategy Guy, so if you’d like to find out… What four streamers had the most misses... HBO’s strong start to 2026… The caveat to Peacock’s turnaround this year... Paramount+’s key man problem… What country isn’t delivering hits for Netflix or Hulu... The cavalcade of stars on a streamer where no one is watching their shows... Across nearly 5,000 words of analysis… And a lot more... ...please subscribe! We can only keep doing this great work with your support. If you’d like to read more about why you should subscribe, please read this article about the Streaming Ratings Report, why it matters, why you need it, and why we cover streaming ratings best.
Data center backlash reveals bugs in the political system - or are they features?
Local officials have more power than they're letting on in the fights over data centers.
S&P 500 falls as AI worries hit software makers
The S&P 500 declined as AI competition fears hit software stocks and Middle East tensions lifted oil prices, with investors eyeing upcoming inflation data.
OpenAI's big math breakthrough claim sparks drama
The math community is heated over questions about credit and AI training data after a mathematician's allegations against OpenAI went viral.
Business Aviation Insight. Reassessing Large-Cabin Value After the Falcon 900LX’s Final Delivery Year
Challenger 650 – Photo Credit: Bombardier The Falcon 900LX and Challenger 650 sit at opposite ends of a large-cabin segment that, on 2026 data, now spans nearly $19 million in …
Trump Administration Asks Supreme Court to Allow Voter-Screening Tool
Voting rights organizations had challenged a Trump administration overhaul of a government database, arguing it could be used to disenfranchise eligible voters.
OECD: Heavy AI Use Linked to Lower Science Scores
New PISA data shows students who use AI daily score 28 points lower in science; OECD urges using AI to support, not replace, learning.
After Causing Delays for 9/11 Health Claims, Social Security Pledges to Do Its Job
Lawyers say the Social Security Administration has for months not provided basic data to complete compensation claims for those sick and dying after exposure to debris from the Sept. 11 attacks.
Health: The Fight For The Health Of 9/11 First Responders
A quarter century after 9/11, the health of those who responded to the attacks continues to be affected.Some 3,000 people died across three locations that day. An estimated 400,000 people were exposed to toxic contaminants and risked physical injury in the hours and days that followed. That’s according to data from the Centers for Disease Control and Prevention.Since the dust and debris have settled, more than 96,000 have been diagnosed with physical and mental health conditions related to 9/11.In 2010, President Barack Obama signed the James Zadroga 9/11 Health and Compensation Act, establishing the World Trade Center Health Program and reopening the 9/11 Victims Compensation Fund. Today, more than 150,000 people are enrolled in the program.But that program wouldn’t exist without the advocacy of survivors and first responders who put their bodies and lives on the line following the attacks. How did that fight for care unfold?For more information about the Rutgers WTC Health Program, click here. And to learn more about applying, click here.Find more of our programs online. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.
Sanford Health Patient Advances Suit Over Meta Data Disclosures
Sanford Health Corp. failed to convince a federal judge to toss a proposed class action alleging the Minnesota-based health system collected and disclosed patients’ personal information in violation of state and federal laws.
Democrats Demand Trump Administration Halt Collection of Patients' ER Records
Senate and House Democrats say the Trump administration’s plan to collect patients’ medical data violates privacy and will discourage people from seeking medical care.
What Formula One Engineering Can Teach Us About AI Infrastructure
Michael Fuller, Executive Chairman of Conflux Technology, examines why thermal performance alone is no longer enough in modern data centers, and how balancing heat transfer with hydraulic efficiency can unlock significant operational gains. The AI era is forcing data center operators to rethink some long-held assumptions about infrastructure design. As processor power densities continue to […]
Are Irving, LaVine, Holiday realistic for Heat? And surprising Richards info
The Heat’s challenges in landing one more impactful player. And some notable data on new backup center Nick Richards.
AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD
With a detailed data drop that AstraZeneca’s R&D chief described as an internal “science success story,” the British Big Pharma has secured an FDA priority review for what it believes could become a flagship biologic in chronic obstructive pulmonary disease (COPD). In detailed results from the late-stage Oberon and Titania trials—first teased in March and detailed in full at the European Respiratory Society Congress in Barcelona this week—the drugmaker laid out the extent of its IL-33 inhibitor’s potential to reduce moderate and severe exacerbations in a wide range of COPD patients still struggling with those “lung attacks,” as AstraZeneca’s Sharon Barr, Ph.D., called them, despite using standard-care inhaled therapy. In the headline results, a 300 mg dose of tozorakimab given once every four weeks curbed those moderate and severe exacerbations in the studies’ primary population of former smokers by 29% in the Oberon study and 34% in Titania. In the overall population of both current and former smokers, these reductions were 30% and 29%, respectively, versus placebo and inhaled standard of care. The benefits also extended to clinically meaningful exacerbation reductions in all prespecified patient subgroups and specifically turned up promising signals in patients across a range of blood eosinophil counts, with Barr telling Fierce that “it’s the details that make this even more exciting than the high-level results that we’ve already shared.” In fact, during AZ’s tozorakimab poster presentation at the ERS 2026 Congress this past weekend, attendees were so enamored by the data that event organizers had to encourage people to clear the room and look at the other presentations on offer, Barr said in an interview. “I think it really speaks to the fact that there is a lot of buzz around these data because the entire respiratory community has been so desperate for new therapies for these patients,” she explained. The respiratory disease continues to represent a “staggering unmet medical need,” Barr said, highlighting the COPD exacerbations that the Oberon and Titania studies homed in on, which she added carry a greater mortality risk than a heart attack. “When a patient has a severe exacerbation, only about half of them are still alive within three and a half years,” she pointed out. As for tozorakimab specifically, Barr christened the molecule “an AstraZeneca science success story,” harkening several years back to the point at which researchers began to explore IL-33 as a driver of respiratory disease, and COPD in particular. At the same time, “there was still so much that wasn’t understood,” she admitted, highlighting the insight that IL-33 signals through both ST2 and EGFR through the RAGE pathway, a discovery Barr attributed to AstraZeneca's own scientists. Understanding the need to tackle both pathways in COPD—and aware of competitor candidates in the hopper, including one that bound ST2—the company ultimately had to make some “courageous decisions,” Barr said. These included taking a prior COPD molecule offline and going back to the drawing board to reinvent its potential IL-33 label “to make sure that we had a molecule that could block signaling through both arms of the pathway, through both the reduced form and the oxidized form, knowing that we wouldn’t be first, but striving to be best.” “When we put [tozorakimab] into the clinic, we firmly believed that we had a differentiated molecule, and we saw the other molecules blocking just ST2 or partially blocking IL-33, unable to deliver two positive pivotal studies in COPD,” Barr explained. “We kept marching forward because we believed our molecule was differentiated, and now I think we have the clinical validation that supports that.” Ultimately, AstraZeneca finds itself on much better footing these days when it comes to potential biologic rivals to tozorakimab in COPD. Sanofi and Regeneron’s Dupixent, for instance, is approved to treat COPD exacerbations in patients with high eosinophil counts, but not low ones. Meanwhile, the future has become cloudier for other next-gen IL-33 candidates from Sanofi and Regeneron, as well as Roche, which have suffered trial flops in recent years. One other potential ingredient for AstraZeneca’s success in its duo of studies was that the company was “ambitious in the trial design, willing to look at an all-comers population,” Barr said, “and willing to enroll the most severe patients.” Prior studies for would-be biologics rivals in COPD “avoided enrolling” those patients, she pointed out. She also highlighted the Big Pharma’s painstaking design of exacerbations in its trial, which “gave us a very rigorous readout,” and pointed to “the extra effort and investment” the company put in to understand the effect of mucus plugs in patients. Barr described mucus production as a “key feature in disease diversity,” noting that mucus plugs—obstructing clumps of mucus that block patients’ airways—are associated with worse outcomes in COPD. In its data announcement, AstraZeneca noted that an integrated analysis of Oberon and Titania found tozorakimab “demonstrated a reduction in patients’ mucus plug score,” with the pharma claiming its biologic is the first to deliver such results in a broad COPD population. “So being able to reduce those mucus plugs, we expect, is an important part of driving benefit for patients who are living with COPD,” Barr said. Again touching on the breadth of the study populations, Barr added that tozorakimab “worked across all eosinophil levels in both current and former smokers across all levels of lung function,” which she suggested “really simplifies decision-making for clinicians, and it allows them to offer therapy to the broadest possible patient population.” In the highest patient eosinophil count group, tozorakimab helped chart a 43% reduction in exacerbation risk, which Barr stressed were “unprecedented data.” In the mid-level group, AZ’s drug delivered a 23% reduction and, in the lowest group, a 34% reduction in eosinophils, which Barr said suggests efficacy “in all patient subgroups.” As for AZ’s recent guidance upgrade on the medicine’s sales opportunity, the lift from a $3 billion to $5 billion range to $5 billion plus was informed by multiple factors, Barr said, including the fact that “in 2024, there were multiple competitors, and there aren’t anymore.” Additionally, “we know that this is a massive unmet medical need, and this is a really incredible set of data that we think will be very convincing to the clinical community,” Barr said. Looking ahead to a potential evolution of the COPD treatment landscape, Barr noted that most patients start treatment in the community with an option like a triple therapy, and for them, having an option like AstraZeneca’s inhaler Breztri will remain a “really important part” of that journey. But of the patients uncontrolled on triple therapy, which Barr described as “about half of them today,” just a “small fraction” are currently eligible for biologic therapy, which she emphasized AstraZeneca is working to change. Understanding that COPD is not a “one-size-fits-all” disease, AstraZeneca is also looking at its antibody drug Tezspire for patients with T2-driven disease, and the company continues to think about new mechanisms for tackling COPD through both systemic and inhaled drugs, Barr said.
Apple Acquires Startup Working on 'Breakthrough Sensing Technology'
Earlier this year, Apple acquired California-based startup Sonera, according to a notice published today on the European Commission's website. Sonera previously announced that it had developed "breakthrough sensing technology" that "non-invasively measures magnetic fields" generated by the brain and body. The company said its technology can analyze neural data without direct skin contact, giving it an advantage over traditional electrical sensing techniques.
Moreno calls to end data center subsidies
Pushback against data centers has grown across the country, including in Ohio.
Provident Behavioral Health Data Breach Exposes SSNs, Medical Info
Got notice about the Provident Behavioral Health data breach? Learn why lawyers are considering a class action suit and what you could be owed.
What Makes Guardant Health (GH) a Compelling Bet?
Artisan Partners, an investment management company, released its second-quarter 2026 investor letter for the “Artisan Mid Cap Fund”. The letter can be downloaded here. Global equities rebounded sharply in Q2 2026, recovering from March lows as resilient economic data, strong corporate earnings, and continued AI investment improved investor sentiment despite inflation concerns, delayed rate cuts, and […]
Global Genes Partners with Citizen Health to Power RARE-X
/PRNewswire/ -- Global Genes has entered a strategic partnership with Citizen Health to provide the technology behind RARE-X, its rare disease data collection...
Why consumer apps set their sights on patient health records
Apps like Doctronic, Sharecare & ChatGPT now let patients access medical records via AI, aided by TEFCA & CMS, though Epic's data-sharing friction remains a hurdle.
Insider Purchase: Chief Business Officer of $NMTC Buys 33,333 Shares
David J. Wambeke, the Chief Business Officer of $NMTC, bought 33,333 shares of the company on 08-27-2026 for an estimated $66,999. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 20.0%. Following this trade, they now own 199,999 shares of this class of $NMTC stock.$NMTC Insider Trading Activity$NMTC insiders have traded $NMTC stock on the ope
Arm Extends AI Reach From Data Centers To Edge Devices
Chip designer Arm previewed new innovations in its AI compute portfolio spanning data centers to edge devices. Arm stock rose Tuesday.
Political strategists outline their plan for Senate control and the algorithm cutting vital Medicaid funding
Plus, the NTSB investigators receive flight recorder data from the aircraft that crashed in Miami.
City Foundry developer suggests entertainment may be the best use for The Armory
Steve Smith wants to get a conversation started about whether The Armory should be converted into office space or kept as an entertainment venue. And the CEO of New + Found says that can’t just be theoretical: Part of developer TerraWatt’s plan to build a data center at the Famous-Barr warehouse next door comes with […]
Jason Tommell | Fisher Associates, P.E., L.S., L.A., D.P.C.
Fisher Associates welcomes Jason Tommell, MBA, PSM, PLS, CFM, PMP, as Director of Land Survey + Data Solutions.
Mark Cuban shares 10 tips for towns negotiating data centers
Cuban urged towns to demand enforceable protections from data centers, emphasizing oversight, water, and noise limits before approval.
Louisville tech firm V-Soft already seeing payoffs from its latest acquisition
V-Soft's acquisition of St. Paul-based Logisolve adds data and AI capabilities, helping the Louisville firm expand its technology consulting offerings.
Colombia business association labels hydrogen a $20bn ‘investment opportunity’
The National Business Association of Colombia (ANDI) believes the country’s hydrogen sector is an “investment opportunity worth over $20bn,” saying a pipeline of announced projects could attract enormous capital.
Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
Washington: Despite fueling AI’s wrong answers, data centers are uniting Dems and the GOP
Politicians from both sides of the aisle are raising strikingly similar concerns about water, energy and costs. The question is how long the unity will last.
11 politicians changing their positions on AI data centers
As public backlash to AI data centers grows, 11 politicians are rethinking incentives, backing new guardrails, or calling for pauses on development.
11 politicians changing their positions on AI data centers
As public backlash to AI data centers grows, 11 politicians are rethinking incentives, backing new guardrails, or calling for pauses on development.
Arm CEO says AI could cure cancer but data centers are a bottleneck
Getting there, however, will require enormous amounts of computing power, Haas said.
Americans' satisfaction with schools is at a low point, new Gallup poll shows
A new poll shows that only 32% of Americans are satisfied with the quality of K-12 education in the country | KNSS Radio
Americans' satisfaction with schools is at a low point, new Gallup poll shows
A new poll shows that only 32% of Americans are satisfied with the quality of K-12 education in the country | 1080 WTIC NEWSTALK
Americans' Satisfaction With Schools Is at a Low Point, New Gallup Poll Shows
Americans' satisfaction with the quality of K-12 education in the country has hit a low point, driven by a growing political divide and concerns that schools are not preparing children for college and future jobs. Just 32% of American adults say they are “completely” or “somewhat” satisfied with the ...
Leading Public Health Through Uncertainty: Insights from the PH WINS Pulse Check
State and local public health workers report growing strain amid recent sociopolitical changes that affect their day-to-day. At de Beaumont’s recent webinar, speakers shared and discussed data from the PH WINS Pulse Check, a 2026 survey designed to gather the perspectives of individual public health workers, including how workforce conditions have shifted since the Public […]
How Art Uncovers the Hidden Pain of Endometriosis
See how ANU PhD candidate Susanne Ilschner goes beyond the diagnosis and clinical data, using abstract paintings to give voice to the unspoken pain of women living with endometriosis.
Mexico Joins PAHO's Regional Mental Health Survey
Mexico joins a 17-country PAHO/WHO survey on doctors' and nurses' mental health, with data collection set for September-October 2026.
Kentucky lawmaker renews push for domestic violence offender registry
People convicted of a qualifying offense would appear in a public database after a second conviction.
A data center in Denmark gives away heat that data centers often waste. It runs water from the city's heating network through its cooling units and into heat pumps that raise it enough to fill the radiators of 11,000 homes
As data centers consume ever more power, one facility in Denmark shows how to turn a costly cooling problem into a heating solution for thousands of households.
Marvell's AI Business Is Booming. Photonics Could Be Next
Data-center revenue jumped 46% as Marvell positions itself for a shift from copper connections toward faster optical technology.
Arizona Land Play Bets on Data Centers and Entertainment to Draw Capital West
Arizona Land Consulting plans a $6 billion to $10 billion Tonopah development mixing data centers, film studios, and an amusement park west of Phoenix.
CO2Meter celebrates 20 years of business
Florida-based gas detection specialist CO2Meter is celebrating 20 years of business, marking two decades of changes in gas detection technology, regulation, and the needs of its customers.
Top Data Science Course in Mumbai with Career Support and On-Job Training
Top Data Science Course in Mumbai with Career Support and On-Job Training
Top Data Science Course in Mumbai with Career Support and On-Job Training
Top Data Science Course in Mumbai with Career Support and On-Job Training
Fake IT Calls Target Executives in Microsoft 365 Data Theft and Extortion Attacks
PREY-0058 uses help desk vishing and AitM token theft to steal data from Microsoft 365 and other SaaS services for extortion.
Gmail change may flood your inbox with political email
Gmail's Verified Sender Program launches September 8, 2026, giving U.S. political committees a more reliable path to your personal email inbox.
‘Mistrust’ of Palantir may affect NHS research, says health minister
James Frith warns patients may be less willing to share data as new figures show a rise in opt-outs
Luminis Health Working to Restore Systems After Cyberattack
Luminis Health in Maryland is investigating a cyberattack that has taken certain systems offline. Data breaches have been announced by Texas Orthopedic Luminis Health in Maryland is investigating a cyberattack that has taken certain systems offline. Data breaches have been announced by Texas Orthopedic surgeon Jeffrey David Reuben, M.D, Well Child in Tennessee, and Horizon Eye Care Laser & Eye Surgery Center in New Jersey.
June 2026 Healthcare Data Breach Report
In June 2026, 66 large healthcare data breaches – data breaches involving the protected health information of 500 or more individuals – were reported to In June 2026, 66 healthcare data breaches affecting 500 or more individuals were reported under HIPAA, and the protected health information of almost 4.5 million Americans was breached.
1 year after approving Project Blue, Pima County releases data center health impact study
Tucson residents were clear in their concerns about Project Blue's potential to impact the environment and public health. Now, health officials in Pima County, where the project is moving forward, have published a study that backs some of that up.
What can the Texas Ag Commissioner do about data centers and flock cameras? We ask the Democratic candidate
Organizer and rancher Clayton Tucker is running against beekeeper and businessman Nate Sheets to be the Texas Commissioner of Agriculture in November. Lone Star Politics talks to him about his quest to take on data center and flock camera companies and what exactly the Ag commissioner can do about those issues.
Aviloo launches independent study on EV battery health
Overall battery health remains strong, however the data shows meaningful differences between models and individual examples of the same model
OpenAI’s ChatGPT for Healthcare is getting wired into Epic
OpenAI added a read-only Epic EHR integration and public health data connectors to ChatGPT for Healthcare. Here’s what hospital IT and ops teams must verify.
The Early Scale: Dreamforce Focuses on AI, But Lacks Concrete ROI Data
Dreamforce emphasizes AI but lacks ROI data. SHRM pushes continuous benefits management, EU delays medtech MDR to 2028.
Early Data Indicates an A.I.-Generated Drug Could Slow Aging
Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition. Its maker says the drug also seems to reduce the biological hallmarks of age.
China's forex reserves rise more than expected in August
BEIJING, Sept 7 (Reuters) - China's foreign exchange reserves rose more than expected in August, central bank data showed on Monday, as the dollar extended its weakness.
Within days of the January 2025 inauguration, more than 3,000 taxpayer-funded federal data sets from the CDC, the Justice Department and the Office of Personnel Management were pulled offline, and Harvard public health researchers held marathon sessions scraping the pages before they vanished
Within days of the January 2025 inauguration, thousands of federal datasets began disappearing from public websites. Researchers scrambled to mirror the pages before they vanished — and much of what was captured cannot fully replace what was lost.
LG smart TVs caught logging audio with screen off and snooping on local devices
An investigation by Gamers Nexus found LG smart TVs sweep local networks to map phones and nearby devices. Tests also showed the sets can capture microphone audio with the screen off — they then upload data once reconnected to the internet.
Bangor’s new fire chief wants to prioritize firefighters’ health
Eric Pelletier, who served as interim chief this summer, takes on the department’s highest role two decades after he joined it.
Korea’s entertainment platforms hit by major data breaches
Popular South Korean entertainment platforms Weverse and Tving are grappling with major data breaches, renewing the spotlight on cybersecurity risks facing the
Phnom Penh recognised with WHO Healthy Cities Award for safer, healthier urban mobility
Phnom Penh City Hall has been awarded the World Health Organization (WHO) Healthy Cities Recognition Awards 2026 in the Safe, Active and Health-enabling Transport category, recognising its commitment to improving road safety and creating healthier urban mobility for residents. The award was presented during the 11th Global Conference of the Alliance for Healthy Cities held in Sydney, Australia, from 1-3 September 2026. Phnom Penh was recognised for the project “Safe, Active and Health-enabling Transport: Advancing Health and Reducing Inequities in Urban Mobility”, supported through the Partnership for Healthy Cities. The initiative has focused on creating safer and more accessible environments for vulnerable road users, particularly around schools. The project combines road safety data, infrastructure improvements, 30 km/h speed management, enforcement, education and community engagement to address risks around high-risk schools. Improvements have included the installation of traffic signs and road markings, smart speed limit signs, safety camera systems and strengthened monitoring in school zones. At the two intervention schools, infrastructure conditions improved from 1.0-star rating to 4.2 and 3.5 stars using the Star Rating for Schools tool. The project also contributed to lower vehicle speeds, provided road safety training for 500 students and achieved a reported 58% reduction in self-reported crashes. iRAP was proud to serve as the technical advisor to the project, supporting evidence-based approaches to infrastructure safety and helping to guide interventions that protect people walking, cycling and travelling to and from school. The WHO recognition is particularly significant given the strong level of regional participation. More than 150 cities from across the Asia-Pacific region applied for the awards, with only eight cities ultimately selected for recognition. The award demonstrates how targeted investment in safer roads and sustainable transport can contribute to healthier, more equitable cities while supporting broader goals for urban development and quality of life. iRAP congratulates the Phnom Penh City Hall and all project partners on this important achievement and looks forward to continuing to support initiatives that deliver safer roads and safer journeys for everyone. Read original article hereRead more on the project here
Talk Business & Politics: Editor Andrew DeMillo and mid-term election analysis
It has been a busy week in Arkansas between the topics of data centers, prison wrangling and healthcare.